Literature DB >> 21212369

Biopsy-proven nonsteatotic liver in adults: estimation of reference range for difference in attenuation between the liver and the spleen at nonenhanced CT.

Yang Shin Park1, Seong Ho Park, Seung Soo Lee, Dae Yoon Kim, Yong Moon Shin, Woochang Lee, Sung-Gyu Lee, Eun Sil Yu.   

Abstract

PURPOSE: To establish the reference range for hepatic attenuation minus splenic attenuation difference (CT(L-S)) values on nonenhanced computed tomographic (CT) images obtained in adults with a biopsy-proved nonsteatotic liver and determine the CT(L-S) criterion for diagnosing hepatic steatosis.
MATERIALS AND METHODS: This retrospective study was institutional review board approved, and all subjects had provided written informed consent. The CT(L-S) was measured in 315 liver donor candidates (207 men, 108 women; mean age, 31.5 years ± 10.1 [standard deviation]) who underwent nonenhanced CT of the liver and subsequent ultrasonographically guided liver biopsy on the same day. Nonenhanced liver CT was performed with a 16-section multidetector scanner in 154 individuals and with a 64-section multidetector scanner in 161 individuals. Biopsy specimens were analyzed for degree of hepatic steatosis and iron deposition. The CT(L-S) reference range was determined according to Clinical and Laboratory Standards Institute guideline C28-A3 in individuals with a histologically proved nonsteatotic liver. The sensitivity of nonenhanced CT for the diagnosis of 5% or greater and 30% or greater hepatic steatosis with use of the lower limit of the reference range as the diagnostic cutoff was determined. The effects of subject age and sex, CT scanner type, and hepatic iron on the CT(L-S) were evaluated by using multiple linear regression analysis.
RESULTS: Ninety-six subjects (48 men, 48 women) were found to have a histologically proved nonsteatotic liver, with an estimated reference range for CT(L-S) values of 1-18 HU. With a CT(L-S) of less than 1 HU as the criterion for hepatic steatosis, the sensitivities of nonenhanced CT for 5% or greater and 30% or greater hepatic steatosis were 18.6% (29 of 156 subjects) and 67% (26 of 39 subjects), respectively. Subject age had a significant but negligible effect on CT(L-S) (0.076-HU increase per year of age, P = .009), subject sex and scanner type had no effects on CT(L-S), and hepatic iron deposition significantly increased the CT(L-S) (1.434-HU increase per increase in iron deposition grade, P = .011).
CONCLUSION: The histologically proved reference range of CT(L-S) values for nonsteatotic livers was 1-18 HU. A CT(L-S) of less than 1 HU could be used as a conservative criterion for diagnosing hepatic steatosis with nonenhanced CT more consistently. © RSNA, 2011.

Entities:  

Mesh:

Year:  2011        PMID: 21212369     DOI: 10.1148/radiol.10101233

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  37 in total

1.  High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial.

Authors:  Stefan B Puchner; Michael T Lu; Thomas Mayrhofer; Ting Liu; Amit Pursnani; Brian B Ghoshhajra; Quynh A Truong; Stephen D Wiviott; Jerome L Fleg; Udo Hoffmann; Maros Ferencik
Journal:  Radiology       Date:  2014-11-04       Impact factor: 11.105

2.  CT indices for the diagnosis of hepatic steatosis using non-enhanced CT images: development and validation of diagnostic cut-off values in a large cohort with pathological reference standard.

Authors:  Jieun Byun; Seung Soo Lee; Yu Sub Sung; Youngbin Shin; Jessica Yun; Ho Sung Kim; Eun Sil Yu; Sung-Gyu Lee; Moon-Gyu Lee
Journal:  Eur Radiol       Date:  2018-12-19       Impact factor: 5.315

Review 3.  Newer CT applications and their alternatives: what is appropriate in children?

Authors:  R Paul Guillerman
Journal:  Pediatr Radiol       Date:  2011-08-17

4.  Automated measurement of liver attenuation to identify moderate-to-severe hepatic steatosis from chest CT scans.

Authors:  Artit Jirapatnakul; Anthony P Reeves; Sara Lewis; Xiangmeng Chen; Teng Ma; Rowena Yip; Xing Chin; Shuang Liu; Ponni V Perumalswami; David F Yankelevitz; Michael Crane; Andrea D Branch; Claudia I Henschke
Journal:  Eur J Radiol       Date:  2019-10-25       Impact factor: 3.528

5.  Validation of goose liver fat measurement by QCT and CSE-MRI with biochemical extraction and pathology as reference.

Authors:  Li Xu; Yangyang Duanmu; Glen M Blake; Chenxin Zhang; Yong Zhang; Keenan Brown; Xiaoqi Wang; Peng Wang; Xingang Zhou; Manling Zhang; Chao Wang; Zhe Guo; Giuseppe Guglielmi; Xiaoguang Cheng
Journal:  Eur Radiol       Date:  2017-12-13       Impact factor: 5.315

6.  Exploring the relationship between nonalcoholic fatty liver disease and pancreatic cancer by computed tomographic survey.

Authors:  Chao-Feng Chang; Yu-Chen Tseng; Hsin-Hung Huang; Yu-Lueng Shih; Tsai-Yuan Hsieh; Hsuan-Hwai Lin
Journal:  Intern Emerg Med       Date:  2017-12-12       Impact factor: 3.397

Review 7.  Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging.

Authors:  Yingzhen N Zhang; Kathryn J Fowler; Gavin Hamilton; Jennifer Y Cui; Ethan Z Sy; Michelle Balanay; Jonathan C Hooker; Nikolaus Szeverenyi; Claude B Sirlin
Journal:  Br J Radiol       Date:  2018-06-06       Impact factor: 3.039

Review 8.  Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease.

Authors:  Mustafa Koplay; Mesut Sivri; Hasan Erdogan; Alaaddin Nayman
Journal:  World J Hepatol       Date:  2015-04-18

9.  Radiographic Improvement of Hepatic Steatosis After Laparoscopic Roux-en-Y Gastric Bypass.

Authors:  Joshua S Winder; Brandon S Dudeck; Sarayna Schock; Jerome R Lyn-Sue; Randy S Haluck; Ann M Rogers
Journal:  Obes Surg       Date:  2017-02       Impact factor: 4.129

Review 10.  Radiologic evaluation of nonalcoholic fatty liver disease.

Authors:  Seung Soo Lee; Seong Ho Park
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.